JINYU(SH:600201)2024-04-25 13:12Financial Performance - Net profit for the first quarter was ¥106,531,343.68, a decrease from ¥110,273,815.05 in the same period last year[26] - The total profit for the quarter was ¥123,564,762.14, down from ¥129,194,288.30 year-over-year[26] - Basic earnings per share remained stable at ¥0.10, unchanged from the previous year[26] - The company reported a total comprehensive income of ¥109,828,615.86, slightly down from ¥110,566,904.67 year-over-year[26] - The company's operating revenue for Q1 2024 was CNY 347,901,401.91, representing a decrease of 4.42% compared to the same period last year[32] - The net profit attributable to shareholders for Q1 2024 was CNY 105,586,820.64, down by 1.05% year-over-year[32] - Total operating revenue for Q1 2024 was CNY 347,901,401.91, a decrease of 4.3% compared to CNY 364,004,443.89 in Q1 2023[48] - Total operating costs for Q1 2024 were CNY 230,815,022.46, down 2.5% from CNY 236,832,424.14 in Q1 2023[48] - Operating profit for Q1 2024 was CNY 123,604,312.08, a slight decrease of 4.3% from CNY 128,927,647.11 in Q1 2023[48] Assets and Liabilities - Total assets at the end of the reporting period reached ¥6,920,700,806.16, an increase of 0.70% compared to the end of the previous year[7] - As of March 31, 2024, total current assets amounted to RMB 2,882,774,330.23, a decrease of 4.4% from RMB 3,015,892,437.34 on December 31, 2023[41] - The total liabilities decreased to RMB 1,144,701,494.69 from RMB 1,217,642,217.42, reflecting a reduction of approximately 6.0%[44] - The company's total assets increased to RMB 6,920,700,806.16 from RMB 6,872,581,837.59, showing a growth of about 0.7%[44] - The total owner's equity rose to RMB 5,775,999,311.47 from RMB 5,654,939,620.17, marking an increase of approximately 2.1%[44] Cash Flow - The net cash flow from operating activities for Q1 2024 was CNY 45,691,311.67, a significant improvement from a negative cash flow of CNY -35,342,581.58 in the same quarter last year[32] - Cash inflows from operating activities totaled CNY 313,905,071.25, an increase from CNY 287,890,157.06 in Q1 2023[32] - Cash outflows from operating activities decreased to CNY 268,213,759.58 from CNY 323,232,738.64 in the same quarter last year[32] - Cash and cash equivalents were reported at RMB 1,674,404,545.05, down from RMB 1,712,198,218.97, indicating a decline of 2.2%[41] - Cash and cash equivalents at the end of Q1 2024 totaled CNY 1,135,949,930.04, compared to CNY 1,229,679,914.78 at the end of Q1 2023[56] - The company reported a net increase in cash and cash equivalents of CNY 83,189,761.83 for Q1 2024, contrasting with a decrease of CNY 36,982,825.31 in Q1 2023[56] Shareholder Information - The number of shareholders holding common stock without restrictions was 122,304,000 for the largest shareholder[16] - The total number of ordinary shareholders at the end of the reporting period was 52,262[35] - The largest shareholder, Inner Mongolia Jinyu Biological Holdings Co., Ltd., held 10.92% of the shares, with 14,110,000 shares pledged[36] Other Financial Metrics - Other comprehensive income after tax amounted to ¥3,297,272.18, compared to ¥293,089.62 in the previous year[26] - Non-recurring gains and losses included CNY 5,086,668.13 from government subsidies closely related to normal business operations[34] - Research and development expenses increased to CNY 31,490,190.73 in Q1 2024, up 21.5% from CNY 25,934,361.97 in Q1 2023[48] - Tax expenses for Q1 2024 were CNY 2,756,330.52, slightly down from CNY 2,803,688.41 in Q1 2023[48] - The company recorded a financial income of CNY 14,860,414.67 in Q1 2024, an increase from CNY 13,219,226.90 in Q1 2023[48] - Other income for Q1 2024 was CNY 5,086,668.13, down from CNY 7,414,301.18 in Q1 2023[48] Operational Insights - The company did not report any significant changes in its operational strategies or new product developments during the quarter[18] - The financial information in the report has not been audited, indicating a need for caution in interpreting the results[11]